Pluristem Therapeutics PSTI
$ 1.03
-1.9%
Quarterly report 2024-Q3
added 11-12-2024
Pluristem Therapeutics Balance Sheet 2011-2024 | PSTI
Annual Balance Sheet Pluristem Therapeutics
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-1.2 M | 1.02 M | -2.65 M | -30.5 M | -6.68 M | -4.11 M | -8.82 M | -4.71 M | -6.22 M | -22.6 M | -4.49 M | -9.01 M | -30.8 M | -42.8 M |
Long Term Debt |
5.03 M | 5.75 M | 6.5 M | 100 K | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
559 K | 627 K | 619 K | 634 K | 1.02 M | - | - | - | - | - | - | - | 13 K | - |
Total Non Current Liabilities |
29.7 M | 29.9 M | 29 M | 24.9 M | 1.44 M | 1.33 M | 1.9 M | 1.87 M | 2.01 M | 3.83 M | 4.5 M | 4.93 M | 4.16 M | 576 K |
Total Current Liabilities |
4.45 M | 5.62 M | 6.83 M | 11.5 M | 7.99 M | 8.16 M | 8.55 M | 5.41 M | 5.78 M | 6.18 M | 7.4 M | 5.92 M | 5.52 M | - |
Total Liabilities |
- | - | - | - | 9.43 M | 9.49 M | 10.5 M | 7.28 M | 7.78 M | 10 M | 11.9 M | 10.8 M | 9.68 M | 2.59 M |
Deferred Revenue |
- | - | - | 40 K | 126 K | - | 640 K | - | - | 472 K | 626 K | 772 K | 792 K | - |
Retained Earnings |
-420 M | -400 M | -371 M | -330 M | -280 M | -251 M | -216 M | -190 M | -162 M | -139 M | -114 M | -86.9 M | -65.7 M | -51 M |
Total Assets |
39.5 M | 50.8 M | 68.1 M | 93.5 M | 65.5 M | 31.3 M | 39 M | 37.5 M | 45.9 M | 68.2 M | 74 M | 68.3 M | 47.4 M | 46 M |
Cash and Cash Equivalents |
6.78 M | 5.36 M | 9.77 M | 31.2 M | 8.27 M | 4.11 M | 8.82 M | 4.71 M | 6.22 M | 22.6 M | 4.49 M | 9.01 M | 9.39 M | 42.8 M |
Book Value |
39.5 M | 50.8 M | 68.1 M | 93.5 M | 56.1 M | 21.8 M | 28.5 M | 30.3 M | 38.2 M | 58.1 M | 62.1 M | 57.5 M | 37.7 M | 43.4 M |
Total Shareholders Equity |
96 K | 13.4 M | 30 M | 57.2 M | 56.1 M | 21.8 M | 28.5 M | 30.3 M | 38.2 M | 58.1 M | 62.1 M | 57.5 M | 37.7 M | 43.4 M |
All numbers in USD currency
Quarterly Balance Sheet Pluristem Therapeutics
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
4.94 M | 5.03 M | 5.4 M | 5.43 M | 5.75 M | 6.03 M | 6.24 M | 6.3 M | 6.5 M | 7.27 M | 7.61 M | 94 K | 100 K | 100 K | 159 K | 385 K | 1.26 M | 1.26 M | 1.26 M | 1.26 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
30.9 M | 29.7 M | 30.4 M | 29.2 M | 29.9 M | 30 M | 29.7 M | 27.8 M | 29 M | 31.2 M | 31.7 M | 24.5 M | 24.9 M | 24.9 M | 1.12 M | 1.66 M | 1.44 M | 1.44 M | 1.96 M | 2.2 M | 1.33 M | 1.33 M | 1.88 M | 1.97 M | 1.9 M | 1.94 M | 1.98 M | 1.82 M | 1.87 M | 1.87 M | 1.81 M | 1.93 M | 2.01 M | 2.01 M | 2.08 M | 3.72 M | 3.83 M | 3.83 M | 4.03 M | 4.15 M | 4.5 M | 4.5 M | 4.92 M | 4.96 M | 4.93 M | 4.93 M | 3.95 K | 4.02 M | 4.16 M | 4.16 M | 4.31 M | 4.5 M | 576 K | 576 K |
Total Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | 40 K | - | - | - | 126 K | - | - | - | - | - | - | - | 640 K | - | - | - | - | - | - | - | - | - | - | 379 K | 379 K | 379 K | 379 K | 379 K | 379 K | 379 K | 379 K | 379 K | 379 K | 379 K | 779 | 779 K | 779 | 779 K | 923 K | 923 K | - | - |
Retained Earnings |
-426 M | -420 M | -409 M | -405 M | -400 M | -393 M | -386 M | -377 M | -371 M | -362 M | -352 M | -341 M | -330 M | -330 M | -301 M | -289 M | -280 M | -280 M | -265 M | -258 M | -251 M | -251 M | -233 M | -224 M | -216 M | -207 M | -205 M | -197 M | -190 M | -190 M | -175 M | -168 M | -162 M | -162 M | -148 M | -144 M | -139 M | -139 M | -126 M | -120 M | -114 M | -114 M | -98.4 M | -91.7 M | -86.9 M | -86.9 M | -74.2 K | -69.7 M | -65.7 M | -65.7 M | -57.4 M | -55.4 M | -51 M | -51 M |
Total Assets |
35.4 M | 39.5 M | 41.6 M | 44.5 M | 50.8 M | 56.2 M | 59.9 M | 59.8 M | 68.1 M | 79.1 M | 81.2 M | 83.7 M | 93.5 M | 93.5 M | 52.3 M | 59 M | 65.5 M | 65.5 M | 24.9 M | 27.6 M | 31.3 M | 31.3 M | 24.3 M | 30.9 M | 39 M | 43 M | 44.7 M | 31 M | 37.5 M | 37.5 M | 32.3 M | 40.2 M | 45.9 M | 45.9 M | 56 M | 60.3 M | 68.2 M | 68.2 M | 58.3 M | 63.8 M | 74 M | 74 M | 71.3 M | 65.5 M | 68.3 M | 68.3 M | 79.1 K | 81.4 M | 47.4 M | 47.4 M | 49.6 M | 49.8 M | 46 M | 46 M |
Cash and Cash Equivalents |
3.2 M | 6.78 M | 5.47 M | 5.25 M | 5.36 M | 3.68 M | 8.82 M | 10 M | 9.77 M | 24.9 M | 19.2 M | 15.2 M | 31.8 M | 31.2 M | 7.82 M | 6.62 M | 8.27 M | 8.27 M | 7.3 M | 3.72 M | 4.11 M | 4.11 M | 6.8 M | 8.43 M | 8.82 M | 5.94 M | 8.58 M | 12.3 M | 8.58 M | 4.71 M | 7.33 M | 6.1 M | 7.33 M | 6.1 M | 4.95 M | 10.8 M | 4.95 M | 10.8 M | 6.96 M | 5.66 M | 6.96 M | 5.66 M | 4.63 M | 8.6 M | 4.63 M | 8.6 M | 23.5 M | 38.8 M | 23.5 K | 38.8 M | 6.67 K | 13.6 M | 6.67 M | 13.6 M |
Book Value |
35.4 M | 39.5 M | 41.6 M | 44.5 M | 50.8 M | 56.2 M | 59.9 M | 59.8 M | 68.1 M | 79.1 M | 81.2 M | 83.7 M | 93.5 M | 93.5 M | 52.3 M | 59 M | 65.5 M | 65.5 M | 24.9 M | 27.6 M | 31.3 M | 31.3 M | 24.3 M | 30.9 M | 39 M | 43 M | 44.7 M | 31 M | 37.5 M | 37.5 M | 32.3 M | 40.2 M | 45.9 M | 45.9 M | 56 M | 60.3 M | 68.2 M | 68.2 M | 58.3 M | 63.8 M | 74 M | 74 M | 71.3 M | 65.5 M | 68.3 M | 68.3 M | 79.1 K | 81.4 M | 47.4 M | 47.4 M | 49.6 M | 49.8 M | 46 M | 46 M |
Total Shareholders Equity |
-5.28 M | 96 K | 4.4 M | 11 M | 13.4 M | 19.1 M | 25 M | 26.9 M | 30 M | 40.1 M | 39.8 M | 48.9 M | 57.2 M | 57.2 M | 41.1 M | 48.9 M | 41.1 M | 48.9 M | 15.9 M | 15.9 M | 15.9 M | 17.5 M | 15.2 M | 15.2 M | 28.5 M | 33.2 M | 37 M | 24.4 M | 37 M | 24.4 M | 25.1 M | 32.9 M | 25.1 M | 32.9 M | 49.3 M | 52.3 M | 49.3 M | 52.3 M | 49.1 M | 53.7 M | 49.1 M | 53.7 M | 60.8 M | 54.8 M | 60.8 M | 54.8 M | 69 M | 72.2 M | 69 K | 37.7 M | 40.4 K | 40.3 M | 40.4 M | 40.3 M |
All numbers in USD currency